Cellectar Biosciences, Inc. — Director's Dealing 2016

Apr 22, 2016

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Cellectar Biosciences, Inc. (CLRB)
CIK: 0001279704
Period of Report: 2016-04-20

Reporting Person: BERNS PAUL L (Director)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2016-04-20	Common Stock, par value $0.00001 per share	P	117371	$2.12	Acquired	117371	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2016-04-20	Series A Warrants	$3.04	P	117371	Acquired	2021-04-20	Common Stock (117371)	Direct